Vyndamax 61 MG capsule UD 30S
Ended Awarded
- Contract number
- SPE2DB25FA3RZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,847
Award facts
- Contract value 100% obligated
- $13,846.97 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $13,846.97 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Vyndamax 61 mg capsules in unit dose packaging (30-count). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of October 6, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply a wide range of medications, vaccines, and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this IDC vehicle. The company holds significant federal contract experience with DLA, consistently delivering medications across multiple therapeutic domains through competitively awarded delivery orders with firm fixed pricing. Vyndamax (tafamidis) is a specialty pharmaceutical used to treat transthyretin amyloidosis, reflecting the sophisticated medical supply requirements supported through DLA's pharmaceutical prime vendor program designed to ensure military and veteran healthcare systems have access to essential medications.
Quick answers
Who was awarded contract SPE2DB25FA3RZ?
SPE2DB25FA3RZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 15, 2025.
How much is contract SPE2DB25FA3RZ worth?
The government has obligated $13,847 on SPE2DB25FA3RZ.
Is contract SPE2DB25FA3RZ an order under another contract?
Yes. SPE2DB25FA3RZ is a delivery order under SPE2DB20D3303, an indefinite delivery contract.
Was contract SPE2DB25FA3RZ competed?
The extent of competition for SPE2DB25FA3RZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award